State of Wisconsin Investment Board Portfolio holdings
AUM
$40.9B
1-Year Return
24.31%
This Quarter Return
+8.7%
1 Year Return
+24.31%
3 Year Return
+99.94%
5 Year Return
+177.86%
10 Year Return
+427.44%
AUM
$48.3B
AUM Growth
+$1.43B
(+3.1%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-4.05%
Top 10 Holdings %
Top 10 Hldgs %
18.69%
Holding
2,219
New
201
Increased
548
Reduced
910
Closed
160
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$57M |
| 2 |
Meta Platforms (Facebook)
META
|
+$53.9M |
| 3 |
Biogen
BIIB
|
+$48.6M |
| 4 |
AstraZeneca
AZN
|
+$47.2M |
| 5 |
Accenture
ACN
|
+$39.4M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$114M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$111M |
| 3 |
SPDR Bloomberg High Yield Bond ETF
JNK
|
+$92.5M |
| 4 |
Microsoft
MSFT
|
+$81.6M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$73.2M |
Sector Composition
| 1 | Technology | 22.49% |
| 2 | Financials | 14.31% |
| 3 | Healthcare | 13.25% |
| 4 | Consumer Discretionary | 11.35% |
| 5 | Communication Services | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Flowers Foods
FLO
$2.91B
| $1M | ﹤0.01% |
41,415
-2,347
| -5% | -$56.8K |
|
1452
Travere Therapeutics
TVTX
$2.08B
| $1M | ﹤0.01% |
68,600
| – | – |
|
|
EPZM
1453
DELISTED
Epizyme, Inc
EPZM
| $997K | ﹤0.01% |
120,000
| – | – |
|
1454
Recursion Pharmaceuticals
RXRX
$2.11B
| $996K | ﹤0.01% |
+27,300
| New | +$996K |
|
1455
Aclaris Therapeutics
ACRS
$212M
| $989K | ﹤0.01% |
+56,300
| New | +$989K |
|
1456
Karyopharm Therapeutics
KPTI
$56.4M
| $985K | ﹤0.01% |
6,360
| – | – |
|
1457
NNN REIT
NNN
$8.14B
| $983K | ﹤0.01% |
20,959
-1,085
| -5% | -$50.9K |
|
1458
AGCO
AGCO
$8.15B
| $972K | ﹤0.01% |
7,452
-121,066
| -94% | -$15.8M |
|
1459
Shattuck Labs
STTK
$92.5M
| $972K | ﹤0.01% |
+33,528
| New | +$972K |
|
1460
Avidity Biosciences
RNA
$5.75B
| $969K | ﹤0.01% |
39,200
+15,600
| +66% | +$386K |
|
1461
Verastem
VSTM
$601M
| $965K | ﹤0.01% |
19,750
| – | – |
|
|
INBX
1462
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $964K | ﹤0.01% |
+35,014
| New | +$964K |
|
|
BDN
1463
Brandywine Realty Trust
BDN
$789M
| $957K | ﹤0.01% |
69,775
-30,009
| -30% | -$412K |
|
1464
QCR Holdings
QCRH
$1.31B
| $957K | ﹤0.01% |
19,900
| – | – |
|
1465
Atossa Therapeutics
ATOS
$108M
| $956K | ﹤0.01% |
+151,300
| New | +$956K |
|
1466
Donaldson
DCI
$9.46B
| $956K | ﹤0.01% |
15,050
-1,052
| -7% | -$66.8K |
|
1467
Theravance Biopharma
TBPH
$720M
| $953K | ﹤0.01% |
65,600
| – | – |
|
1468
Rhythm Pharmaceuticals
RYTM
$6.39B
| $948K | ﹤0.01% |
48,400
| – | – |
|
1469
Commerce Bancshares
CBSH
$7.96B
| $947K | ﹤0.01% |
15,441
-838
| -5% | -$51.4K |
|
1470
United Therapeutics
UTHR
$18.3B
| $946K | ﹤0.01% |
5,271
-233
| -4% | -$41.8K |
|
1471
ITT
ITT
$13.9B
| $943K | ﹤0.01% |
10,291
-671
| -6% | -$61.5K |
|
1472
ScottsMiracle-Gro
SMG
$3.51B
| $941K | ﹤0.01% |
4,903
-236
| -5% | -$45.3K |
|
|
JBGS
1473
JBG SMITH
JBGS
$1.45B
| $939K | ﹤0.01% |
29,809
+14,362
| +93% | +$452K |
|
1474
Alaska Air
ALK
$7.32B
| $933K | ﹤0.01% |
15,465
-20,551
| -57% | -$1.24M |
|
1475
Bruker
BRKR
$4.69B
| $928K | ﹤0.01% |
12,219
-877
| -7% | -$66.6K |
|